AreteiaTx
Lex Kay is an accomplished professional in the pharmaceutical industry, currently serving as the V.P. Global Head of Quality at AreteiaTx since July 2022. Prior to this role, Lex Kay was the Principal at Kay Quality/GMP Compliance LLC, providing specialized consulting services in Manufacturing, Quality, and Logistics from July 2021 to July 2022. Lex Kay also held significant positions at Shionogi Inc as Vice President of Quality Assurance from January 2011 to June 2021, and at Columbia Laboratories as Senior Director of Operations from January 2001 to January 2011.
AreteiaTx
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication ofimproving lung function and is found in several asthma-related treatments.